Jackson Leron C, Camacho Fabian, Levine Edward A, Anderson Roger T, Stewart John H
Department of Surgery, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA.
Am J Surg. 2008 Feb;195(2):164-9. doi: 10.1016/j.amjsurg.2007.10.001.
Ductal carcinoma in situ (DCIS) of the breast comprises approximately 25% of new breast cancer cases. The aim of this study was to delineate patterns of care for women with DCIS as related to age, tumor characteristics, and race/ethnicity. Further study goals included the identification of predictors of breast-conserving surgery (BCS), adjuvant radiation, and/or hormonal therapy, as well as breast reconstruction after mastectomy.
The North Carolina Cancer Registry was queried for primary DCIS treated in 1998 and 1999 (n = 1,893). Logistic regression analysis was performed to define the determinants of patterns of care.
Thirty-five percent of the women in this study sample underwent mastectomy. Positive predictors of mastectomy included young age (age <50 y vs 70+; odds ratio [OR], 1.55; 95% confidence interval [CI], 1.13-2.11) and larger tumor size (>2 mm vs 0-1 mm; OR, 2.43; 95% CI, 1.63-3.60). Approximately 48% of women who underwent BCS received adjuvant radiation therapy. Factors associated with receiving radiation therapy after BCS include younger age (age <50 vs 70+; OR, 2.12; 95% CI, 1.49-3.03). Approximately 19% of women who underwent BCS received adjuvant hormonal therapy. Positive predictors of receiving adjuvant hormonal therapy after BCS included age of 50 to 60 years versus 70+ (OR, 2.16; 95% CI, 1.36-3.44) and the receipt of radiation therapy (OR, 3.60; 95% CI, 2.55-5.06). Approximately 28% of women who underwent mastectomy received breast reconstruction surgery. Positive predictors of breast reconstruction after mastectomy included age younger than 50 years versus 70+ years (OR, 47.36; 95% CI, 19.45-115.32). African American race was associated negatively with receipt of breast reconstruction after mastectomy (OR, .46; 95% CI, .26-.84).
Treatment strategies for primary surgical therapy for DCIS vary significantly by age. Inconsistencies exist surrounding the use of adjuvant radiation therapy after BCS in women with DCIS. Variations in approaches to reconstructive surgery after mastectomy may be related to age, ethnicity, and/or economic constraints.
乳腺导管原位癌(DCIS)约占新发乳腺癌病例的25%。本研究的目的是描绘与年龄、肿瘤特征及种族/民族相关的DCIS女性的治疗模式。进一步的研究目标包括确定保乳手术(BCS)、辅助放疗和/或激素治疗的预测因素,以及乳房切除术后的乳房重建。
查询北卡罗来纳州癌症登记处1998年和1999年治疗的原发性DCIS病例(n = 1,893)。进行逻辑回归分析以确定治疗模式的决定因素。
本研究样本中35%的女性接受了乳房切除术。乳房切除术的阳性预测因素包括年轻(年龄<50岁与70岁以上;优势比[OR],1.55;95%置信区间[CI],1.13 - 2.11)和肿瘤较大(>2 mm与0 - 1 mm;OR,2.43;95% CI,1.63 - 3.60)。接受BCS的女性中约48%接受了辅助放疗。BCS后接受放疗的相关因素包括年龄较小(年龄<50岁与70岁以上;OR,2.12;95% CI,1.49 - 3.03)。接受BCS的女性中约19%接受了辅助激素治疗。BCS后接受辅助激素治疗的阳性预测因素包括年龄50至60岁与70岁以上(OR,2.16;95% CI,1.36 - 3.44)以及接受放疗(OR,3.60;95% CI,2.55 - 5.06)。接受乳房切除术的女性中约28%接受了乳房重建手术。乳房切除术后乳房重建的阳性预测因素包括年龄小于50岁与70岁以上(OR,47.36;95% CI,19.45 - 115.32)。非裔美国人种族与乳房切除术后接受乳房重建呈负相关(OR,0.46;95% CI,0.26 - 0.84)。
DCIS原发性手术治疗的策略因年龄而异。DCIS女性BCS后辅助放疗的使用存在不一致之处。乳房切除术后重建手术方法的差异可能与年龄、种族和/或经济限制有关。